SEC Form 13F
| Report period | 2024-12-31 |
|---|---|
| Publicly available | 2025-02-15 |
| Reported value | $616,414,127 |
| Positions | 15 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| REVOLUTION MEDICINES INC | RVMD | COM | $332,471,545 | 7,601,087 |
| TYRA BIOSCIENCES INC | TYRA | COM | $56,376,468 | 4,055,861 |
| ORIC PHARMACEUTICALS INC | ORIC | COM | $42,655,712 | 5,285,714 |
| CARGO THERAPEUTICS INC | CRGX | COM | $38,104,879 | 2,642,502 |
| ARVINAS INC | ARVN | COM | $26,998,913 | 1,408,394 |
| MERSANA THERAPEUTICS INC | Unresolved | COM | $17,256,162 | 12,067,246 |
| TANGO THERAPEUTICS INC | TNGX | COM | $17,099,998 | 5,533,980 |
| ZYMEWORKS INC | ZYME | COM | $16,308,169 | 1,113,946 |
| RELAY THERAPEUTICS INC | RLAY | COM | $15,847,205 | 3,846,409 |
| CULLINAN ONCOLOGY INC | CGEM | COM | $13,899,146 | 1,141,145 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.